Literature DB >> 2023279

Antigens of lung cancer: results of the second international workshop on lung cancer antigens.

R L Souhami1, P C Beverley, L G Bobrow, J A Ledermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2023279     DOI： 10.1093/jnci/83.9.609

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  12 in total

1.  Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: an immunocytochemical study.

Authors:  P Athanassiadou; M Gonidi; A Liossi; E Petrakakou; L Nakopoulou; C Zerva; P Athanassiades
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.

Authors:  E J Derbyshire; R A Stahel; E J Wawrzynczak
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 3.  New perspectives in lung cancer. 3. The antigens of lung cancer.

Authors:  R L Souhami
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

4.  Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis.

Authors:  Diandian Li; Bo Wang; Qianjing Hu; Yongchun Shen; Dan Xu; Tao Wang; Fuqiang Wen
Journal:  Tumour Biol       Date:  2014-03-08

5.  Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer.

Authors:  D Ornadel; J A Ledermann; K Eagle; R B Pedley; G Boxer; S E Ward; Y Olabiran; J Bomanji
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

6.  An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.

Authors:  L G Bobrow; F R Hirsch; F G Hay; L Happerfield; B G Skov; K Law; R C Leonard; R L Souhami
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

7.  The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.

Authors:  Y Olabiran; J A Ledermann; N J Marston; G M Boxer; R Hicks; R L Souhami; S G Spiro; R A Stahel
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

8.  Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts.

Authors:  K Rygaard; C Møller; E Bock; M Spang-Thomsen
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

9.  Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.

Authors:  U Zangemeister-Wittke; A R Collinson; B Frösch; R Waibel; T Schenker; R A Stahel
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 9.075

10.  Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.

Authors:  E J Derbyshire; L de Leij; E J Wawrzynczak
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.